Immunohistochemical detection of sepsis-induced lung injury in human autopsy material

Legal Medicine

Volumn 5, Issue 2, 2003, Pages 73-86

  Tsokos, Michael ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Adhesion molecule; E selectin; Endothelium; Expression pattern; Forensic pathology; ICAM 1; Immunohistochemistry; Lactoferrin; Lectin; Leukocyte; Neutrophil; Sepsis; Systemic inflammatory response syndrome; Vascular endothelial growth factor; VLA 4

Indexed keywords

ALPHA 2,6 GALACTOSE; ALPHA N ACETYLGALACTOSAMINE; ALPHA4 INTEGRIN; ARACHIS HYPOGAEA AGGLUTININ; AUTACOID; BETA1 INTEGRIN; BIOCHEMICAL MARKER; CARBOHYDRATE; CELL ADHESION MOLECULE; CHEMOTACTIC PEPTIDE; CONCANAVALIN A; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN; GRIFFONIA SIMPLICIFOLIA I AGGLUTININ; GRIFFONIA SIMPLICIFOLIA II AGGLUTININ; INTERCELLULAR ADHESION MOLECULE 1; JACALIN; LACTOFERRIN; LECTIN; LIMULUS POLYPHEMUS AGGLUTININ; MAACKIA AMURENSIS AGGLUTININ; MACLURA POMIFERA AGGLUTININ; MANNOSE; N ACETYLNEURAMINIC ACID; SAMBUCUS NIGRA AGGLUTININ; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; VASCULOTROPIN; WHEAT GERM AGGLUTININ;

AUTOPSY; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BINDING SITE; BRONCHUS MUCOSA; DEATH; ENDOTHELIUM CELL; FATALITY; FORENSIC PATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTENSIVE CARE; LEUKOCYTE; LUNG ALVEOLUS CELL; LUNG INJURY; LYMPHOCYTE; MACROPHAGE; MICROVASCULATURE; NEUTROPHIL; PATHOGENESIS; PATHOPHYSIOLOGY; PROTECTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REVIEW; SEPSIS; STAINING; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

EID: 0038817864     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1344-6223(03)00010-5     Document Type: Review

References (70)

1. Tsokos M, Püschel K. Iatrogenic Staphylococcus aureus septicaemia following intravenous and intramuscular injections: Clinical course and pathomorphological findings. Int J Legal Med 1999;112:303-8.
2. Tsokos M. Pathology of sepsis. I. Forensic problems arising in the postmortem diagnosis of death due to sepsis. Jpn J Forens Pathol 2002;8:72-7.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
4. Bone RC. The sepsis syndrome: Definition and general approach to management. Clin Chest Med 1996;17:175-81.
5. Talvik R, Liigant A, Tapfer H, Tamme K, Metsvaht T. Septic shock with disseminated microfoci in multiple organs in humans. Intensive Care Med 1998;24:73-6.
6. Adrie C, Pinsky MR. The antiflammatory balance in human sepsis. Intensive Care Med 2000;26:364-75.
7. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
8. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-8.
9. Bone RC. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-7.
10. Ebnet K, Vestweber D. Molecular mechanisms that control leukocyte extravasation: The selectins and the chemokines. Histochem Cell Biol 1999;112:1-23.
11. Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, Ward PA. Mechanisms of enhanced lung injury during sepsis. Am J Pathol 1999;154:1057-65.
12. Kaplan RL, Sahn SA, Petty TL. Incidence and outcome of respiratory distress syndrome in gram-negative sepsis. Arch Intern Med 1979;139:867-9.
13. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiological significance. Am Rev Respir Dis 1986;133:218-25.
14. Ertel W, Morrison MH, Wang P, Zheng F, Ayala A, Chaudry ICH. The complex patterns of cytokines in sepsis. Ann Surg 1991;214:141-8.
15. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21:258-63.
16. Tracey KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg 1990;23:21-56.
17. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996;64:4733-8.
18. Wichtermann KA, Bauer AE, Chaudry ICH. Sepsis and shock: A review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
19. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA. Interleukin 1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985;121:393-403.
20. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988;133:426-33.
21. Strieter RM, Kunkel SL. Acute lung injury: The role of cytokines in the elicitation of neutrophils. J Invest Med 1994;42:640-51.
22. Butcher EC. Leukocyte-endothelial cell recognition: Three (ore more) steps to specificity and diversity. Cell 1991;67:1033-6.
23. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
24. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6.
25. Lukacs NW, Ward PA. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv Immunol 1996;62:257-304.
26. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1990;76:301-14.
27. Lasky LA. Lectin cell adhesion molecules (LEC-CAMs): A new family of cell adhesion proteins involved with inflammation. J Cell Biochem 1991;45:139-46.
28. Lasky LA. Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-8.
29. Ley K, Allietta M, Bullard DC, Morgan S. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ Res 1998;83:287-94.
30. Tsokos M, Fehlauer F, Püschel K. Immunohistochemical expression of E-selectin in sepsis-induced lung injury. Int J Legal Med 2000;113:338-42.
31. Drake TA, Cheng J, Chang A, Taylor FB. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993;142:1458-70.
32. Redl H, Dinges HP, Buurman WA, Van Der Linden CJ, Pober JS, Cotran RS, Schlag G. Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Pathol 1991;139:461-6.
33. Schultz MJ, Rijneveld AW, Van Deventer SJH, Van Der Poll T. Cytokines and host defense in pneumonia. Intensivmedizin 1999;36:270-5.
34. Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer R, Zacchi T, Harlan JM, Patriarca P. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late acivation antigen-4 integrin receptor. J Clin Invest 1991;88:20-6.
35. Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol 1995;154:4099-112.
36. Kassner PD, Teixidó J, Chan BM, Parker CM, Hemler ME. Analyses of VLA-4 structure and function. Adv Exp Med Biol 1992;323:163-70.
37. Li XC, Miyasaka M, Issekutz TB. Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4 dependent and independent pathways. J Immunol 1998;161:6258-64.
38. Tsokos M, Fehlauer F. Postmortem markers of sepsis: A quantitative immunohistochemical study using VLA-4 (CD49d/CD29) and ICAM-1 (CD54) for the detection of sepsis-induced lung injury. Int J Legal Med 2001;114:291-4.
39. Krüll M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Hegemann JH, Jantos CA, Suttorp N. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999;162:4834-41.
40. Baynes RD, Bezwoda WR. Lactoferrin and the inflammatory response. In: Hutchens TW, Rumball SV, Lönnerdal B, editors. Lactoferrin. Structure and Function. New York/London: Plenum, 1994. p. 133-41.
41. Britigan BE, Serody JS, Cohen MS. The role of lactoferrin as an anti-inflammatory molecule. In: Hutchens TW, Rumball SV, Lönnerdal B, editors. Lactoferrin. Structure and Function. New York/London: Plenum, 1994. p. 142-53.
42. Jeremy B. Lactoferrin: A multifunctional immunoregulatory protein? Immunol Today 1995;16:417-9.
43. Lonnerdal B, Iyer S. Lactoferrin: Molecular structure and biological function. Annu Rev Nutr 1995;15:93-110.
44. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977;197:263-5.
45. Boxer LA, Coates TD, Haak RA, Wolach JB, Hoffstein S, Baehner RL. Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med 1982;307:404-10.
46. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988;109:127-42.
47. Oseas R, Yang HH, Baehner RL, Boxer LA. Lactoferrin: A promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981;57:939-45.
48. Tsokos M, Paulsen F. Expression of pulmonary lactoferrin in sudden-onset and slow-onset asthma with fatal outcome. Virchows Arch 2002;441:494-9.
49. Tsokos M, Anders S, Paulsen F, Fehlauer F, Püschel K. Comparative evaluation of pulmonary lactoferrin and lysozyme immunoreactivity for the postmortem diagnosis of death due to sepsis. Virchows Arch 2001;438:376-81.
50. Damjanov I. Lectin cytochemistry and histochemistry. Lab Invest 1987;57:5-20.
51. Danguy A, Decaestecker C, Genten F, Salmon I, Kiss R. Applications of lectins and neoglycoconjugates in histology and pathology. Acta Anat (Basel) 1998;161:206-18.
52. Goldstein IJ, Hayes CE. The lectins: Carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem 1978;35:127-340.
53. Kaltner H, Stierstorfer B. Animal lectins as cell adhesion molecules. Acta Anat (Basel) 1998;161:162-79.
54. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-69.
55. Hachiya T, Honda T, Kubo K, Sekiguchi M. Expression patterns of type II pneumocyte apical surface glycoconjugates in lung adenocarcinoma cells. Virchows Arch 1999;434:63-9.
56. Zhou Q, Cummings RD. Animal lectins: A distinct group of carbohydrate-binding proteins involved in cell adhesion, molecular recognition, and development. In: Fukuda M, editor. Cell Surface Carbohydrates and Cell Development. Boca Raton, FL: CRC Press, 1992. p. 99-113.
57. Sivridis E, Giatromanolaki A, Koukourakis M, Agnantis N. Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: The prognostic value of concanavalin A. Virchows Arch 2000;436:52-8.
58. West KP, Cope JL. The binding of peroxidase-labelled lectins to human endometrium in normal cyclical endometrium and endometrial adenocarcinoma. J Clin Pathol 1989;42:140-7.
59. Tsokos M, Anders S, Paulsen F. Lectin binding patterns of alveolar epithelium and subepithelial seromucous glands of the bronchi in sepsis and controls - An approach to characterize the non-specific immunological response to the human lung to sepsis. Virchows Arch 2002;440:181-6.
60. Dvorak HF, Detmar M, Claffey KP, Nagy JA, Van De Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995;107:233-5.
61. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999;77:527-43.
62. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000;55:15-36.
63. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995;95:1798-807.
64. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997;16:557-67.
65. Christou H, Yoshida A, Arthur V. Morita T, Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1998;18:768-76.
66. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000;161:1877-80.
67. Tsokos M, Pufe T, Paulsen F, Anders S, Mentlein R. Pulmonary expression of vascular endothelial growth factor in sepsis. Arch Pathol Lab Med 2003; in press.
68. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 1992;3:211-20.
69. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993;264:C995-C1002.
70. Matsuyama W, Hashiguchi T, Matsumuro K, Iwami F, Hirotsu Y, Kawabata M, Arimura K, Osame M. Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Care Med 2000;162:1120-2.